AMBARELLA INC NASDAQ RI false 0001280263 0001280263 2025-02-26 2025-02-26

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

February 26, 2025

Date of Report (date of earliest event reported)

 

 

AMBARELLA, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Cayman Islands   001-35667   98-0459628

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I. R. S. Employer

Identification No.)

3101 Jay Street

Santa Clara, CA 95054

(Address of principal executive offices)

Registrant’s telephone number, including area code: (408) 734-8888

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Ordinary Shares, $0.00045 par value   AMBA   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 2.02

Results of Operations and Financial Condition

On February 26, 2025, Ambarella, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year 2025 ended January 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.

The information in this current report on Form 8-K and the exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits

 

99.1    Press Release dated February 26, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: February 26, 2025     Ambarella, Inc.
     

/s/ John A. Young

      Chief Financial Officer

Exhibit 99.1

Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

February 26, 2025 --Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced fourth quarter and full year fiscal 2025 financial results for the period ended January 31, 2025.

 

   

Revenue for the fourth quarter of fiscal 2025 was $84.0 million, up 62.8% from $51.6 million in the same period in fiscal 2024. For the fiscal year ended January 31, 2025, revenue was $284.9 million, up 25.8% from $226.5 million for the fiscal year ended January 31, 2024.

 

   

Gross margin under U.S. generally accepted accounting principles (GAAP) for the fourth quarter of fiscal 2025 was 60.0%, compared with 59.8% for the same period in fiscal 2024. For the fiscal year ended January 31, 2025, GAAP gross margin was 60.5%, compared with 60.4% for the fiscal year ended January 31, 2024.

 

   

GAAP net loss for the fourth quarter of fiscal 2025 was $20.2 million, or loss per diluted ordinary share of $0.48, compared with a GAAP net loss of $60.6 million, or loss per diluted ordinary share of $1.50, for the same period in fiscal 2024. GAAP net loss for the fiscal year ended January 31, 2025 was $117.1 million, or loss per diluted ordinary share of $2.84. This compares with GAAP net loss of $169.4 million, or loss per diluted ordinary share of $4.25, for the fiscal year ended January 31, 2024.

Financial results on a non-GAAP basis for the fourth quarter and full year fiscal 2025 are as follows:

 

   

Gross margin on a non-GAAP basis for the fourth quarter of fiscal 2025 was 62.0%, compared with 62.5% for the same period in fiscal 2024. For the fiscal year ended January 31, 2025, non-GAAP gross margin was 62.7%, compared with 63.3% for the fiscal year ended January 31, 2024.

 

   

Non-GAAP net profit for the fourth quarter of fiscal 2025 was $4.8 million, or earnings per diluted ordinary share of $0.11. This compares with non-GAAP net loss of $9.8 million, or loss per diluted ordinary share of $0.24, for the same period in fiscal 2024. Non-GAAP net loss for the fiscal year ended January 31, 2025 was $6.8 million, or loss per diluted ordinary share of $0.16. This compares with non-GAAP net loss of $33.1 million, or loss per diluted ordinary share of $0.83, for the fiscal year ended January 31, 2024.

Based on information available as of today, Ambarella is offering the following guidance for the first quarter of fiscal year 2026, ending April 30, 2025:

 

   

Revenue is expected to be between $81.0 million and $87.0 million

 

   

Gross margin on a non-GAAP basis is expected to be between 61.0% and 62.5%

 

   

Non-GAAP operating expenses are expected to be between $50.0 million and $53.0 million


Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the impact of stock-based compensation, acquisition-related costs and restructuring expense adjusted for the associated tax impact, which includes the effect of any benefits or shortfalls recognized. Non-GAAP financial information also excludes the impact of the recognition or release of a valuation allowance on certain deferred tax assets. A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings (losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable debt securities on hand at the end of the fourth quarter of fiscal 2025 was $250.3 million, compared with $226.5 million at the end of the prior quarter and $219.9 million at the end of the same quarter a year ago.

“We finished fiscal 2025 with strong results and are starting the new year with positive momentum. We exited the year with more than 70% of our total revenue from edge AI, representing both a quarterly and annual record. Cumulatively, we have shipped about 30 million edge AI processors, with each SoC integrating our proprietary deep learning AI accelerator,” said Fermi Wang, President & CEO. “In fiscal 2026, we anticipate mid to high teens revenue growth, led by our 5nm products, including the ongoing ramp in the CV5 family and now the CV7 family, which generated production revenue for the first time in Q4. Together with a focus on efficient operations, we intend to continue to drive positive operating leverage.”

Quarterly Conference Call

Ambarella plans to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and John Young, Chief Financial Officer, to discuss the fourth quarter of fiscal year 2025 results. A live and archived webcast of the call will be available on Ambarella’s website at http://www.ambarella.com/ for up to 30 days after the call.

About Ambarella

Ambarella’s products are used in a wide variety of human vision and edge AI applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving and robotics applications. Ambarella’s low-power systems-on-chip (SoCs) offer high-resolution video compression, advanced image and radar processing, and powerful deep neural network processing to enable intelligent perception, fusion and planning. For more information, please visit www.ambarella.com.


“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,” “projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” “should,” or similar expressions, including the guidance for the first quarter of fiscal year 2026 ending April 30, 2025, and the comments of our CEO relating to our expectation of future revenue growth, customer demand and the growth potential for our edge AI inference products, including our CV5 and CV7 families of products, and our ability to generate positive operating leverage in future periods. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, global economic and political conditions; changes in government policies, including possible trade tariffs and restrictions; revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; our customers’ ability to manage their inventory requirements; our growth strategy; our ability to anticipate future market demands and future needs of our customers, particularly for AI inference applications; our ability to introduce, and to generate revenue from, new and enhanced solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as computer vision, AI functionality and advanced networks, including vision-language models and GenAI; our ability to retain and expand customer relationships and to achieve design wins; the expansion of our current markets and our ability to successfully enter new markets, such as the OEM automotive and robotics markets; anticipated trends and challenges, including competition, in the markets in which we operate; risks associated with global health conditions and associated risk mitigation measures; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form 10-K for our 2024 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also set forth in the company’s quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC’s web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Annual Report on Form 10-K for the fiscal year ended January 31, 2025 could differ from the preliminary results announced in this press release.

Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.

Non-GAAP Financial Measures

The company has provided in this release non-GAAP financial information, including non-GAAP gross margin, net income (loss), and earnings (losses) per share, as a supplement to the consolidated financial statements, which are prepared in accordance with generally accepted accounting principles (“GAAP”). Management uses these non-GAAP financial measures internally in analyzing the company’s financial


results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non-GAAP results are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from non-GAAP measures used by other companies.

With respect to its financial results for the fourth quarter of fiscal year 2025, the company has provided below reconciliations of its non-GAAP financial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the first quarter of fiscal year 2026, a reconciliation of non-GAAP gross margin and non-GAAP operating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAP measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.

AMBARELLA, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

(unaudited)

 

     Three Months Ended January 31,     Twelve Months Ended January 31,  
     2025     2024     2025     2024  

Revenue

   $ 84,015     $ 51,616     $ 284,865     $ 226,474  

Cost of revenue

     33,634       20,763       112,535       89,657  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     50,381       30,853       172,330       136,817  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Research and development

     56,823       51,992       226,109       215,052  

Selling, general and administrative

     18,911       20,575       72,816       76,325  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     75,734       72,567       298,925       291,377  

Loss from operations

     (25,353     (41,714     (126,595     (154,560

Other income, net

     2,360       2,107       8,867       6,030  
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (22,993     (39,607     (117,728     (148,530

Provision (benefit) for income taxes

     (2,759     21,000       (602     20,887  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (20,234   $ (60,607   $ (117,126   $ (169,417
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share attributable to ordinary shareholders:

        

Basic

   $ (0.48   $ (1.50   $ (2.84   $ (4.25
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

   $ (0.48   $ (1.50   $ (2.84   $ (4.25
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares used to compute net loss per share attributable to ordinary shareholders:

        

Basic

     41,828,944       40,384,743       41,303,287       39,878,872  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     41,828,944       40,384,743       41,303,287       39,878,872  
  

 

 

   

 

 

   

 

 

   

 

 

 


The following tables present details of stock-based compensation, acquisition-related costs and restructuring expense included in each functional line item in the consolidated statements of operations above:

 

     Three Months Ended January 31,      Twelve Months Ended January 31,  
     2025      2024      2025      2024  
     (unaudited, in thousands)  

Stock-based compensation:

           

Cost of revenue

   $ 931      $ 647      $ 3,270      $ 3,341  

Research and development

     18,372        17,950        73,025        72,759  

Selling, general and administrative

     8,245        9,923        31,748        35,216  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation

   $ 27,548      $ 28,520      $ 108,043      $ 111,316  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three Months Ended January 31,      Twelve Months Ended January 31,  
     2025      2024      2025      2024  
     (unaudited, in thousands)  

Acquisition-related costs:

           

Cost of revenue

   $ 757      $ 757      $ 3,028      $ 3,028  

Research and development

     —         —         —         —   

Selling, general and administrative

     456        520        2,016        2,080  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total acquisition-related costs

   $ 1,213      $ 1,277      $ 5,044      $ 5,108  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three Months Ended January 31,     Twelve Months Ended January 31,  
     2025      2024     2025      2024  
     (unaudited, in thousands)  

Restructuring expense:

          

Cost of revenue

   $ —       $ —      $ —       $ 66  

Research and development

     —         36       —         708  

Selling, general and administrative

     —         68       —         182  
  

 

 

    

 

 

   

 

 

    

 

 

 

Total restructuring expense

   $ —       $ 104     $ —       $ 956  
  

 

 

    

 

 

   

 

 

    

 

 

 

The difference between GAAP and non-GAAP gross margin was 2.0% and 2.7%, or $1.7 million and $1.4 million, for the three months ended January 31, 2025 and 2024, respectively. The difference between GAAP and non-GAAP gross margin was 2.2% and 2.9%, or $6.3 million and $6.4 million, for the fiscal years ended January 31, 2025 and 2024, respectively. The differences were due to the effect of stock-based compensation, amortization of acquisition-related costs and restructuring expense.


AMBARELLA, INC.

RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS (LOSSES) PER SHARE

(in thousands, except share and per share data)

 

     Three Months Ended January 31,     Twelve Months Ended January 31,  
     2025     2024     2025     2024  
     (unaudited)  

GAAP net loss

   $ (20,234   $ (60,607   $ (117,126   $ (169,417

Non-GAAP adjustments:

        

Stock-based compensation expense

     27,548       28,520       108,043       111,316  

Acquisition-related costs

     1,213       1,277       5,044       5,108  

Restructuring expense

     —        104       —        956  

Income tax effect

     (3,760     20,881       (2,744     18,971  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP net income (loss)

   $ 4,767     $ (9,825   $ (6,783   $ (33,066
  

 

 

   

 

 

   

 

 

   

 

 

 

GAAP - diluted weighted average shares

     41,828,944       40,384,743       41,303,287       39,878,872  

Non-GAAP - diluted weighted average shares

     42,533,654       40,384,743       41,303,287       39,878,872  

GAAP - diluted net loss per share

   $ (0.48   $ (1.50   $ (2.84   $ (4.25

Non-GAAP adjustments:

        

Stock-based compensation expense

     0.66       0.71       2.62       2.79  

Acquisition-related costs

     0.03       0.03       0.12       0.13  

Restructuring expense

     —        —        —        0.02  

Income tax effect

     (0.09     0.52       (0.06     0.48  

Effect of Non-GAAP - diluted weighted average shares

     (0.01     —        —        —   

Non-GAAP - diluted net income (loss) per share

   $ 0.11     $ (0.24   $ (0.16   $ (0.83


AMBARELLA, INC.

CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands)

 

     January 31,     January 31,  
     2025     2024  

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 144,622     $ 144,914  

Marketable debt securities

     105,643       75,013  

Accounts receivable, net

     29,767       24,950  

Inventories

     34,428       29,043  

Restricted cash

     7       7  

Prepaid expenses and other current assets

     6,084       6,230  
  

 

 

   

 

 

 

Total current assets

     320,551       280,157  

Property and equipment, net

     9,084       10,439  

Intangible assets, net

     47,279       55,136  

Operating lease right-of-use assets, net

     5,188       5,250  

Goodwill

     303,625       303,625  

Other non-current assets

     3,241       3,048  
  

 

 

   

 

 

 

Total assets

   $ 688,968     $ 657,655  
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

     21,775       28,503  

Accrued and other current liabilities

     80,781       48,598  

Operating lease liabilities, current

     2,829       3,443  

Income taxes payable

     1,383       1,541  

Deferred revenue, current

     14,226       894  
  

 

 

   

 

 

 

Total current liabilities

     120,994       82,979  

Operating lease liabilities, non-current

     2,436       1,896  

Other long-term liabilities

     4,126       12,909  
  

 

 

   

 

 

 

Total liabilities

     127,556       97,784  
  

 

 

   

 

 

 

Shareholders’ equity:

    

Preference shares

     —        —   

Ordinary shares

     19       18  

Additional paid-in capital

     813,683       694,967  

Accumulated other comprehensive loss

     (233     (183

Accumulated deficit

     (252,057     (134,931
  

 

 

   

 

 

 

Total shareholders’ equity

     561,412       559,871  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 688,968     $ 657,655  
  

 

 

   

 

 

 

Contact:

Louis Gerhardy

408.636.2310

lgerhardy@ambarella.coml

v3.25.0.1
Document and Entity Information
Feb. 26, 2025
Cover [Abstract]  
Entity Registrant Name AMBARELLA INC
Security Exchange Name NASDAQ
Entity Incorporation State Country Code RI
Amendment Flag false
Entity Central Index Key 0001280263
Document Type 8-K
Document Period End Date Feb. 26, 2025
Entity File Number 001-35667
Entity Tax Identification Number 98-0459628
Entity Address, Address Line One 3101 Jay Street
Entity Address, City or Town Santa Clara
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95054
City Area Code (408)
Local Phone Number 734-8888
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Ordinary Shares, $0.00045 par value
Trading Symbol AMBA
Entity Emerging Growth Company false

Ambarella (NASDAQ:AMBA)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Ambarella Charts.
Ambarella (NASDAQ:AMBA)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Ambarella Charts.